Physician profile
Bailey Delaney
NPI 1447094636
$1,239.81
in general payments reported to CMS, 2019-2025
13 companies · $1,240 in 2025
The $1,240 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,239.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $406.52 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $258.08 | 2025 | Breztri, Airsupra, Farxiga |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $116.90 | 2025 | Xifaxan |
| Amgen INC. | $95.62 | 2025 | Otezla, Repatha, Evenity |
| Novo Nordisk INC | $91.86 | 2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $56.10 | 2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Seqirus USA INC | $54.13 | 2025 | Flucelvax, Fluad |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.11 | 2025 | Jardiance |
| Exact Sciences Corporation | $26.18 | 2025 | The Cologuard Plus Collection Kit |
| Astellas Pharma US INC | $25.41 | 2025 | Veozah |
| Pfizer INC. | $24.77 | 2025 | |
| Lilly USA, LLC | $19.28 | 2025 | Zepbound |
| Renalytix Ai, INC. | $16.85 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bailey Delaney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.